Picture of Balchem logo

BCPC — Balchem Share Price

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-11.13%
3m-5.27%
6m+9.2%
1yr-0.12%
Volume Change (%)
10d/3m-16.62%
Price vs... (%)
52w High-14.08%
50d MA-8.74%
200d MA+4.93%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)35.7
PEG Ratio (f)2.65
EPS Growth (f)15.56%
Dividend Yield (f)0.4%
Valuation (ttm)IndustryMarket
Price to Book Value5.45
Price to Tang. Book18.48
Price to Free Cashflow37.79
Price to Sales6.33
EV to EBITDA28.29

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital11.41%
Return on Equity10.92%
Operating Margin15.99%

Financial Summary

Year End 31st DecUnit201620172018201920202021E2022ECAGR / Avg
Total Revenue$m553.2594.79643.68643.71703.64785.05844.214.96%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-5.79+14.33+18.89+4.48+5.84+35.31+15.56n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for BCPC

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of Balchem EPS forecast chart

Profile Summary

Balchem Corporation is engaged in developing, manufacturing, distributing and marketing of specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company operates through three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health (HNH) segment provides human grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. HNH segment also serves the food and beverage industry for beverage, bakery, dairy, confectionary, and savory manufacturers. Its Animal Nutrition & Health (ANH) segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment sells ethylene oxide as a sterilant gas primarily for use in the healthcare industry.

Directors

Last Annual
December 31st, 2020
Last Interim
September 30th, 2021
Incorporated
January 30th, 1967
Public Since
June 3rd, 1986
No. of Shareholders
69
No. of Employees
1,305
Sector
Food & Tobacco
Industry
Consumer Defensives
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
32,381,611

BCPC Share Price Performance

Similar to BCPC

Picture of Alico logo

Alico

us flag iconNASDAQ Global Select Market

Picture of Andersons logo

Andersons

us flag iconNASDAQ Global Select Market

Picture of Appharvest logo

Appharvest

us flag iconNASDAQ Global Select Market

Picture of Beyond Meat logo

Beyond Meat

us flag iconNASDAQ Global Select Market

Picture of Calavo Growers logo

Calavo Growers

us flag iconNASDAQ Global Select Market

FAQ

Or unlock with your email

Or unlock with your email